✦ LIBER ✦

A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/013) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain

✍ Scribed by Gordon Irving; Janos Pénzes; Brian Ramjattan; Michael Cousins; Richard Rauck; Egilius L.H. Spierings; Christi S. Kleoudis; Jerry W. Snidow; Amy Pierce; John Wurzelmann; Eric R. Mortensen

Book ID: 118476998
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 597 KB
Volume: 12
Category: Article
ISSN: 1528-8447
DOI: 10.1016/j.jpain.2010.06.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Placebo-Controlled Phase 3

A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/012) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain

✍ Jan-Peter Jansen; Daniel Lorch; John Langan; Ben Lasko; Kai Hermanns; Christi S. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 592 KB

Alvimopan, a peripherally acting mu-opio

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

✍ Lynn Webster; Jan Peter Jansen; John Peppin; Ben Lasko; Gordon Irving; Bart Morl 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 723 KB